Soleus Capital Management, L.P. Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$2.0T
Holdings
88
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (88 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRYSKRYSTAL BIOTECH INC | 1,018,831 | $179.9B | 9.05% | |
| 2 | TGTXTG THERAPEUTICS INC | 3,844,731 | $138.9B | 6.99% | |
| 3 | NVCRNOVOCURE LTD | 9,644,872 | $124.6B | 6.27% | |
| 4 | XBISPDR SERIES TRUST | 1,150,000 | $115.2B | 5.80% | Put |
| 5 | ELVELEVANCE HEALTH INC FORMERLY | 259,650 | $83.9B | 4.22% | |
| 6 | BBNXBETA BIONICS INC | 3,870,158 | $76.9B | 3.87% | |
| 7 | UTHUNITED THERAPEUTICS CORP DEL | 150,000 | $62.9B | 3.17% | |
| 8 | TERNTERNS PHARMACEUTICALS INC | 8,127,100 | $61.0B | 3.07% | |
| 9 | CELCCELCUITY INC | 1,178,860 | $58.2B | 2.93% | |
| 10 | INSPINSPIRE MED SYS INC | 728,188 | $54.0B | 2.72% | |
| 11 | TWSTTWIST BIOSCIENCE CORP | 1,866,234 | $52.5B | 2.64% | |
| 12 | ARGXARGENX SE | 69,426 | $51.2B | 2.58% | |
| 13 | ORGOORGANOGENESIS HLDGS INC | 12,131,699 | $51.2B | 2.58% | |
| 14 | BMRNBIOMARIN PHARMACEUTICAL INC | 890,304 | $48.2B | 2.43% | |
| 15 | CDTXCIDARA THERAPEUTICS INC | 493,811 | $47.3B | 2.38% | |
| 16 | PRAXPRAXIS PRECISION MEDICINES I | 859,166 | $45.5B | 2.29% | |
| 17 | AM6AMICUS THERAPEUTICS INC | 4,690,000 | $37.0B | 1.86% | |
| 18 | —INDIVIOR PLC | 1,466,000 | $35.3B | 1.78% | |
| 19 | MDGLMADRIGAL PHARMACEUTICALS INC | 68,336 | $31.3B | 1.58% | |
| 20 | BSFAANI PHARMACEUTICALS INC | 340,243 | $31.2B | 1.57% | |
| 21 | SNDXSYNDAX PHARMACEUTICALS INC | 2,012,110 | $31.0B | 1.56% | |
| 22 | AXGNAXOGEN INC | 1,726,553 | $30.8B | 1.55% | |
| 23 | NPCENEUROPACE INC | 2,957,957 | $30.5B | 1.54% | |
| 24 | GRFSGRIFOLS S A | 2,500,000 | $24.9B | 1.25% | |
| 25 | GONGERON CORP | 17,290,000 | $23.7B | 1.19% | |
| 26 | NRIXNURIX THERAPEUTICS INC | 2,422,833 | $22.4B | 1.13% | |
| 27 | IARTINTEGRA LIFESCIENCES HLDGS C | 1,440,818 | $20.6B | 1.04% | |
| 28 | NBIXNEUROCRINE BIOSCIENCES INC | 138,000 | $19.4B | 0.98% | |
| 29 | ANABANAPTYSBIO INC | 626,040 | $19.2B | 0.97% | |
| 30 | EDAEDAP TMS S A | 7,309,254 | $16.7B | 0.84% | |
| 31 | PHVSPHARVARIS N V | 647,052 | $16.1B | 0.81% | |
| 32 | VCELVERICEL CORP | 497,953 | $15.7B | 0.79% | |
| 33 | CCCCC4 THERAPEUTICS INC | 7,053,942 | $15.7B | 0.79% | |
| 34 | BLTEBELITE BIO INC | 210,000 | $15.5B | 0.78% | |
| 35 | VCYTVERACYTE INC | 422,055 | $14.5B | 0.73% | |
| 36 | RAPTRAPT THERAPEUTICS INC | 537,903 | $13.9B | 0.70% | |
| 37 | URGNUROGEN PHARMA LTD | 679,000 | $13.5B | 0.68% | |
| 38 | STAASTAAR SURGICAL CO | 500,000 | $13.4B | 0.68% | |
| 39 | SIONSIONNA THERAPEUTICS INC | 413,500 | $12.2B | 0.61% | |
| 40 | CGONCG ONCOLOGY INC | 290,000 | $11.7B | 0.59% | |
| 41 | QUREUNIQURE NV | 200,000 | $11.7B | 0.59% | |
| 42 | QDELQUIDELORTHO CORP | 375,000 | $11.0B | 0.56% | |
| 43 | MIRMMIRUM PHARMACEUTICALS INC | 148,696 | $10.9B | 0.55% | |
| 44 | ADMAADMA BIOLOGICS INC | 738,000 | $10.8B | 0.54% | |
| 45 | IKTINHIBIKASE THERAPEUTICS INC | 6,325,000 | $10.2B | 0.52% | |
| 46 | GMEDGLOBUS MED INC | 176,000 | $10.1B | 0.51% | |
| 47 | GSKGSK PLC | 220,000 | $9.5B | 0.48% | |
| 48 | RI2RIGEL PHARMACEUTICALS INC | 330,010 | $9.3B | 0.47% | |
| 49 | EOLSEVOLUS INC | 1,450,000 | $8.9B | 0.45% | |
| 50 | VSTMVERASTEM INC | 935,909 | $8.3B | 0.42% | |
| 51 | ACLXARCELLX INC | 100,000 | $8.2B | 0.41% | |
| 52 | NUVLNUVALENT INC | 88,000 | $7.6B | 0.38% | |
| 53 | ALNYALNYLAM PHARMACEUTICALS INC | 15,250 | $7.0B | 0.35% | |
| 54 | JBIOJADE BIOSCIENCES INC | 796,744 | $6.9B | 0.35% | |
| 55 | LBRXLB PHARMACEUTICALS INC | 400,000 | $6.3B | 0.32% | |
| 56 | OLMAOLEMA PHARMACEUTICALS INC | 619,874 | $6.1B | 0.31% | |
| 57 | KNSAKINIKSA PHARMACEUTICALS INTL | 150,000 | $5.8B | 0.29% | |
| 58 | ESTAESTABLISHMENT LABS HLDGS INC | 139,512 | $5.7B | 0.29% | |
| 59 | MBXMBX BIOSCIENCES INC | 275,000 | $4.8B | 0.24% | |
| 60 | ERASERASCA INC | 2,162,162 | $4.7B | 0.24% | |
| 61 | ETONETON PHARMACEUTICALS INC | 200,000 | $4.3B | 0.22% | |
| 62 | CBLLCERIBELL INC | 360,000 | $4.1B | 0.21% | |
| 63 | HROWHARROW INC | 85,498 | $4.1B | 0.21% | |
| 64 | GUTSFRACTYL HEALTH INC | 2,500,000 | $4.0B | 0.20% | |
| 65 | JSPRJASPER THERAPEUTICS INC | 1,494,420 | $3.6B | 0.18% | |
| 66 | NSPRINSPIREMD INC | 1,470,934 | $3.5B | 0.18% | |
| 67 | AKROAKERO THERAPEUTICS INC | 71,000 | $3.4B | 0.17% | |
| 68 | IDYAIDEAYA BIOSCIENCES INC | 100,000 | $2.7B | 0.14% | |
| 69 | TNGXTANGO THERAPEUTICS INC | 300,000 | $2.5B | 0.13% | |
| 70 | CBIOCRESCENT BIOPHARMA INC. | 200,000 | $2.4B | 0.12% | |
| 71 | RAPPRAPPORT THERAPEUTICS INC | 80,000 | $2.4B | 0.12% | |
| 72 | KIDSORTHOPEDIATRICS CORP | 128,000 | $2.4B | 0.12% | |
| 73 | IOVAIOVANCE BIOTHERAPEUTICS INC | 976,707 | $2.1B | 0.11% | |
| 74 | CALCCALCIMEDICA INC | 683,904 | $2.1B | 0.11% | |
| 75 | VTGNVISTAGEN THERAPEUTICS INC | 550,000 | $2.0B | 0.10% | |
| 76 | MNKDMANNKIND CORP | 300,000 | $1.6B | 0.08% | |
| 77 | IMUXIMMUNIC INC | 1,580,007 | $1.4B | 0.07% | |
| 78 | AVU0ADVERUM BIOTECHNOLOGIES INC | 287,246 | $1.3B | 0.07% | |
| 79 | LQDALIQUIDIA CORPORATION | 50,000 | $1.1B | 0.06% | |
| 80 | EPIEURESSA PHARMA INC | 4,362,026 | $833.1M | 0.04% | |
| 81 | MYOMYOMO INC | 704,275 | $628.2M | 0.03% | |
| 82 | MREOMEREO BIOPHARMA GROUP PLC | 299,711 | $617.4M | 0.03% | |
| 83 | TECXTECTONIC THERAPEUTIC INC | 25,000 | $392.3M | 0.02% | |
| 84 | IM8NINSMED INC | 2,550 | $367.2M | 0.02% | |
| 85 | SEPNSEPTERNA INC | 18,260 | $343.5M | 0.02% | |
| 86 | KODKODIAK SCIENCES INC | 19,644 | $321.6M | 0.02% | |
| 87 | TRVITREVI THERAPEUTICS INC | 25,000 | $228.8M | 0.01% | |
| 88 | DCTHDELCATH SYS INC | 10,000 | $107.5M | 0.01% |